Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shenzhen Kangtai Biological Pr (300601 CH)
Watchlist
57
Analysis
Health Care
•
China
Shenzhen Kangtai Biological Products Co., Ltd. operates biological product manufacturing businesses. The Company produces biological vaccines and other vaccine products. Shenzhen Kangtai Biological Products conducts businesses in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
HKEX
•
19 Nov 2023 05:30
Index Rebalance & ETF Flow Recap: FRTIB, Japan, CSI300, CSI500, STAR50, WuXi XDC, Asahi
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
652 Views
Share
bullish
•
Luoyang Xinqianglian Slewing B
•
20 Jul 2023 19:49
Quiddity Primer for CSI 300/500 Index Rebalance Events
We evaluated the performance of 1205+ unique past Index rebalance cases (ADDs and DELs) involving the CSI 300 index and CSI 500 index from December...
Janaghan Jeyakumar, CFA
Follow
835 Views
Share
bullish
•
Jiangsu Hoperun Software
•
05 Nov 2024 16:45
Quiddity Leaderboard ChiNext Dec 24: Several Last-Minute Surprises; New Trade Idea
We estimate one-way flows of US$578mn for the ChiNext index rebalance and US$171mn for the ChiNext 50 rebalance in December 2024.
Janaghan Jeyakumar, CFA
Follow
230 Views
Share
bearish
•
Jiangsu Hoperun Software
•
31 Oct 2024 05:30
ChiNext/ChiNext50 Index Rebalance Preview: Jiangsu Hoperun's Multiple Index Inclusions & Big Risk
Review period ends today. We see 8 Chinext, 5 Chinext50 changes. Jiangsu Hoperun will have US$430m to buy, plus flows from CSI trackers, plus...
Brian Freitas
Follow
369 Views
Share
bullish
•
Jiangsu Hoperun Software
•
15 Oct 2024 13:23
Quiddity Leaderboard ChiNext Dec 24: US$400mn Expected Inflow for Jiangsu Hoperun
We estimate US$539mn and US$179mn one-way flows for ChiNext and ChiNext 50. Out of this, Jiangsu Hoperun (300339 CH) alone could see a massive...
Janaghan Jeyakumar, CFA
Follow
607 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x